Cure Pharmaceuticals will pay $20 million in cash and stock upfront, with an additional $4 million in working capital that will focus on fueling growth.
The combination will add Tech-Holdings’ The Gold Q and AntiDos brands to Vertical Wellness' portfolio and enable it to offer proprietary products to its partners, the companies said.
The partnership will offer data via the Lotame Data Exchange, providing mainstream marketers with previously hard-to-find CBD audience data for data enrichment, targeting and analytics.
The Los Angeles-based company said its new EWG Verified status makes it the first hemp CBD brand to meet the evaluator’s standards for chemical safety in consumer products.